MAFFEI, Rossana
 Distribuzione geografica
Continente #
NA - Nord America 9.798
AS - Asia 3.685
EU - Europa 3.498
SA - Sud America 454
Continente sconosciuto - Info sul continente non disponibili 112
AF - Africa 92
OC - Oceania 38
Totale 17.677
Nazione #
US - Stati Uniti d'America 9.542
GB - Regno Unito 1.046
SG - Singapore 974
CN - Cina 814
HK - Hong Kong 799
IT - Italia 781
VN - Vietnam 414
SE - Svezia 370
DE - Germania 342
BR - Brasile 336
BD - Bangladesh 209
FI - Finlandia 200
RU - Federazione Russa 176
UA - Ucraina 136
CA - Canada 127
FR - Francia 124
TR - Turchia 99
IN - India 72
KR - Corea 61
BG - Bulgaria 51
ID - Indonesia 50
NL - Olanda 47
ES - Italia 42
AU - Australia 38
IE - Irlanda 32
AR - Argentina 31
JP - Giappone 28
ZA - Sudafrica 27
BE - Belgio 26
MX - Messico 25
IQ - Iraq 24
PL - Polonia 24
CL - Cile 21
AE - Emirati Arabi Uniti 19
CZ - Repubblica Ceca 19
MA - Marocco 17
PK - Pakistan 17
CR - Costa Rica 16
JM - Giamaica 15
PH - Filippine 15
VE - Venezuela 14
CO - Colombia 13
EC - Ecuador 13
UZ - Uzbekistan 13
IL - Israele 12
AT - Austria 11
RO - Romania 11
TT - Trinidad e Tobago 11
MY - Malesia 10
PE - Perù 10
SV - El Salvador 10
CH - Svizzera 9
DK - Danimarca 9
HN - Honduras 9
JO - Giordania 9
KE - Kenya 9
LT - Lituania 9
PR - Porto Rico 8
GP - Guadalupe 7
PY - Paraguay 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
GT - Guatemala 6
SA - Arabia Saudita 6
BZ - Belize 5
DO - Repubblica Dominicana 5
TW - Taiwan 5
BO - Bolivia 4
GR - Grecia 4
HR - Croazia 4
SC - Seychelles 4
SN - Senegal 4
TN - Tunisia 4
AL - Albania 3
BY - Bielorussia 3
CY - Cipro 3
IR - Iran 3
KZ - Kazakistan 3
NI - Nicaragua 3
PT - Portogallo 3
QA - Qatar 3
RS - Serbia 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
EE - Estonia 2
GY - Guiana 2
HU - Ungheria 2
KG - Kirghizistan 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
SI - Slovenia 2
Totale 17.546
Città #
Ashburn 1.072
Ann Arbor 792
Hong Kong 791
Fairfield 784
Southend 733
Santa Clara 660
Singapore 579
Woodbridge 469
Houston 422
Chandler 415
San Jose 401
Seattle 318
Cambridge 272
Council Bluffs 265
Wilmington 247
Nyköping 243
Jacksonville 215
Hefei 199
Dearborn 196
Los Angeles 178
Chicago 168
Beijing 157
Helsinki 150
London 147
Modena 145
New York 137
Ho Chi Minh City 123
Hanoi 98
The Dalles 91
Milan 90
Munich 71
Salt Lake City 64
San Diego 63
Seoul 59
Fremont 57
Princeton 56
Lauterbourg 51
Sofia 51
Boardman 46
Eugene 46
Izmir 45
Moscow 45
Buffalo 43
Columbus 43
Dallas 40
Rome 39
Bologna 35
Bremen 35
Jakarta 35
Tampa 35
Dublin 32
São Paulo 32
Frankfurt am Main 30
Phoenix 30
Atlanta 28
Orem 28
Brussels 26
Toronto 26
Shanghai 25
Elk Grove Village 24
Miami 24
Montreal 24
Redwood City 23
Melbourne 22
Warsaw 21
North Bergen 20
Brooklyn 19
Des Moines 19
Tokyo 19
Da Nang 18
Lancaster 18
Denver 16
Chennai 15
Haiphong 15
Vancouver 15
Dong Ket 14
Falls Church 14
Naples 14
Brno 13
Tashkent 13
Amsterdam 12
Miano 12
Reggio Emilia 12
Bari 11
Dulles 11
Jinan 11
Kent 11
Newark 11
Rio de Janeiro 11
Ankara 10
Baghdad 10
Boston 10
Guangzhou 10
Johannesburg 10
Madrid 10
Ninh Bình 10
Perugia 10
Philadelphia 10
San Francisco 10
San José 10
Totale 12.365
Nome #
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 846
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 618
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 463
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 448
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 414
Mucorales-specific T cells in patients with hematologic malignancies 393
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 392
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 391
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 378
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 375
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 374
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 365
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 356
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 353
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 348
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 345
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 343
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 342
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 338
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 334
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 333
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 328
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 325
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 322
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 320
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 320
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 318
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 316
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 313
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 300
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 299
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 298
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 298
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 298
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 294
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 294
HOXA homeogene cluster interruption and dysregulation of HOAX9 in the blast crisis of Philadelphia chromosome-positive chronic myeloid leukemia. 293
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 285
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study 282
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 279
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance. 268
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 268
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 266
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 265
Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS 246
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 213
IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia. 207
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 193
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line. 189
Performance trade-offs of different rake receivers 189
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 186
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 185
NOX-A12: Mobilizing CLL away from home 159
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study 145
The dynamic functions of IRF4 in B cell malignancies 128
Optical genome mapping reveals multiple apoptotic and cell-cycle pathway aberrations in B-cell prolymphocytic leukemia: a report of three cases 79
GENOMIC SCREENING OF PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA WITHOUT TP53 ALTERATIONS BY OPTICAL GENOME MAPPING (OGM) 51
OPTICAL GENOME MAPPING IDENTIFIES MULTIPLE STRUCTURAL VARIATION AND CATASTROPHIC REARRANGEMENTS IN B-CELL PROLYMPHOCYTIC LEUKEMIA 46
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia 39
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 24
Totale 17.677
Categoria #
all - tutte 65.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.819


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022720 0 0 0 0 29 82 53 53 97 84 215 107
2022/20231.247 128 156 103 114 168 164 15 145 134 12 53 55
2023/2024800 28 36 51 85 149 68 86 110 15 24 63 85
2024/20252.728 82 49 29 194 409 354 180 135 610 129 217 340
2025/20265.551 337 703 324 594 871 326 613 219 464 451 323 326
2026/20271.478 140 280 383 597 78 0 0 0 0 0 0 0
Totale 17.677